全球體學化驗服務市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計體學化驗服務市場將從 2025 年的 1,035.2 億美元成長到 2034 年的 3,417.4 億美元，2026 年至 2034 年的複合年成長率為 14.19%。

由於基因組學、蛋白質組學和代謝體學研究的需求不斷成長，全球體學化驗服務市場正在擴張。這些服務為個人化醫療、藥物研發和疾病診斷等領域的前沿研究提供支援。生命科學研究投入的增加以及慢性病盛行率的上升是推動市場成長的主要因素。研究機構和製藥公司擴大將體學服務外包給專業實驗室。

關鍵成長要素包括定序技術和生物資訊學工具的技術進步。基因測序成本的降低使得體學研究更容易進行。人們對精準醫療和標靶治療日益成長的興趣也推動了對全面體學分析的需求。此外，政府資助和合作研究計劃正在加速全球體學研究的擴展。

展望未來，由於多組體學方法的不斷創新，市場預計將顯著成長。人工智慧和巨量資料分析的融合有望提高研究效率並加深洞見。新興經濟體生物技術和製藥業的擴張將創造新的服務機會。隨著個人化醫療日益重要，體學實驗室服務將在塑造醫學研究和治療方法發展的未來中發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球體學化驗服務市場：依服務類型分類

• 市場分析、洞察與預測
• 基因組學
• 蛋白質體學
• 轉錄組分析
• 代謝體學
• 表觀遺傳學

第5章 全球體學化驗服務市場：依最終用途分類

• 市場分析、洞察與預測
• 硬體設備（設備、套件、晶片）
• 檢測/實驗室（服務）
• 分析/解釋（個人化和解釋）

第6章 全球體學化驗服務市場：依產品分類

• 市場分析、洞察與預測
• 一度
• 轉發
• 連續的

第7章 全球體學化驗服務市場：依服務頻率分類

• 市場分析、洞察與預測
• 醫院
• 研究機構
• 診斷檢查室

第8章 全球體學化驗服務市場：依業務類型分類

• 市場分析、洞察與預測
• 癌症
• 藥品（處方箋藥、非處方藥）
• 生殖
• 其他基因檢測
• 法醫學
• 人口普查
• 護膚
• 營養
• 維生素和補充劑
• 系譜
• 其他類別

第9章 全球體學化驗服務市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Agilent Technologies Inc
  • Beijing Genomics Institute（BGI）
  • Q2 Solutions
  • Spectrus
  • Flomics Biotech
  • PhenoSwitch Bioscience
  • Qiagen
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc

The Omics Lab Services Market size is expected to reach USD 341.74 Billion in 2034 from USD 103.52 Billion (2025) growing at a CAGR of 14.19% during 2026-2034.

The Global Omics Lab Services Market is expanding due to the increasing demand for genomics, proteomics, and metabolomics research. These services support advanced studies in personalized medicine, drug discovery, and disease diagnostics. Rising investments in life sciences research and the growing prevalence of chronic diseases are key factors driving market growth. Research institutions and pharmaceutical companies are increasingly outsourcing omics services to specialized laboratories.

Major growth drivers include technological advancements in sequencing technologies and bioinformatics tools. The decreasing cost of genomic sequencing has made omics research more accessible. Growing interest in precision medicine and targeted therapies is also fueling demand for comprehensive omics analysis. Additionally, government funding and collaborative research projects are encouraging the expansion of omics-based studies worldwide.

Looking forward, the market is expected to witness significant growth due to continuous innovation in multi-omics approaches. Integration of artificial intelligence and big data analytics will improve research efficiency and insights. Expansion of biotechnology and pharmaceutical industries in emerging economies will create new service opportunities. As personalized healthcare becomes more prominent, omics lab services will play a crucial role in shaping the future of medical research and treatment development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Services

• Genomics
• Proteomics
• Transcriptomic
• Metabolomics
• Epigenetics

By End-Use

• Hardware Equipment (Instrument, Kits, Chips)
• Testing / Lab (Services)
• Analytics / Interpretation (Personalization and Interpretation)

By Product

• One-off
• Repeat
• Continuous

By Frequency of Service

• Hospitals
• Research Institutes
• Diagnostic Labs

By Business

• Cancer
• Pharmaco (Prescription, Non-Prescription)
• Reproductive
• Other Genetic Tests
• Forensics
• Population Studies
• Skincare
• Nutrition
• Vitamins and Supplements
• Genealogy
• Other Categories

COMPANIES PROFILED

• Agilent Technologies Inc, Beijing Genomics Institute BGI, Q2 Solutions, Spectrus, Flomics Biotech, PhenoSwitch Bioscience, Qiagen, Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL OMICS LAB SERVICES MARKET: BY SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Services
• 4.2. Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Transcriptomic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Metabolomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Epigenetics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL OMICS LAB SERVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-use
• 5.2. Hardware Equipment (Instrument, Kits, Chips) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Testing / Lab (Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Analytics / Interpretation (Personalization and Interpretation) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL OMICS LAB SERVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Product
• 6.2. One-off Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Repeat Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Continuous Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL OMICS LAB SERVICES MARKET: BY FREQUENCY OF SERVICE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Frequency Of Service
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Diagnostic Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL OMICS LAB SERVICES MARKET: BY BUSINESS 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Business
• 8.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Pharmaco (Prescription, Non-Prescription) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Reproductive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Other Genetic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.7. Population Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.8. Skincare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.9. Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.10. Vitamins and Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.11. Genealogy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.12. Other Categories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL OMICS LAB SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Services
  • 9.2.2 By End-use
  • 9.2.3 By Product
  • 9.2.4 By Frequency Of Service
  • 9.2.5 By Business
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Services
  • 9.3.2 By End-use
  • 9.3.3 By Product
  • 9.3.4 By Frequency Of Service
  • 9.3.5 By Business
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Services
  • 9.4.2 By End-use
  • 9.4.3 By Product
  • 9.4.4 By Frequency Of Service
  • 9.4.5 By Business
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Services
  • 9.5.2 By End-use
  • 9.5.3 By Product
  • 9.5.4 By Frequency Of Service
  • 9.5.5 By Business
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Services
  • 9.6.2 By End-use
  • 9.6.3 By Product
  • 9.6.4 By Frequency Of Service
  • 9.6.5 By Business
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL OMICS LAB SERVICES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Agilent Technologies Inc
  • 11.2.2 Beijing Genomics Institute (BGI)
  • 11.2.3 Q2 Solutions
  • 11.2.4 Spectrus
  • 11.2.5 Flomics Biotech
  • 11.2.6 PhenoSwitch Bioscience
  • 11.2.7 Qiagen
  • 11.2.8 Quest Diagnostics Incorporated
  • 11.2.9 Thermo Fisher Scientific Inc